article thumbnail

The Fastest Growing Companies in Boston Hiring For Sales

CloserIQ

Founded 2014. Drift provides a conversational sales and marketing platform that allows businesses to better connect with prospects and customers. Founded 2014. Cybereason’s workplace culture is known to be fast-paced and competitive, with plenty of opportunities for learning. Founded 2014. Founded 2014.

Sales 76
article thumbnail

Liron Fendell

Cadensee

Until back in 2014, I met the team at Schneider Children's Medical Center of Israel. So, this was a prospective, randomized, double blind, placebo-controlled study. How do you are you dealing with competition in that market? Yes, so actually, I grew up in Tel Aviv in Israel and I'm originally a corporate lawyer.

Retail 52
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

Amgen scores Otezla patent win in court to keep competition at bay

Pharmaceutical Technology

This is one of several patent infringement cases Amgen has pursued in recent years to stave competition. Despite this legal win, Amgen still faces a competitive psoriasis market as other drugs enter the landscape. The FDA first approved Otezla in March 2014 for the treatment of psoriatic arthritis. Patent No.

article thumbnail

Exforge antitrust settlement caps Novartis’ year of legal disputes

Pharmaceutical Technology

The agreement outlined that Par would keep its generic equivalent off the market for as many as two years, delaying the generic launch till September 30, 2014. We highlight the most impactful emerging technologies, as well as the industry, regulatory, and macroeconomic factors that influence growth prospects.

article thumbnail

FDA grants access to new class of paediatric diabetes medicine

Pharmaceutical Technology

The FDA first approved Jardiance to help control blood sugar in adults with T2D in 2014. As the COVID-19 pandemic continues to take its toll on businesses worldwide, it’s time to look for new ways to create value, prepare for the future, and remain competitive in the ever-changing landscape.

article thumbnail

The “Medical Bypass”: new drugs to strike obesity

Pharmaceutical Technology

The company’s weight loss drug Saxenda (liraglutide) won an approval for chronic weight management in December 2014, and Wegovy (semaglude) got the same tag in 2021. We highlight the most impactful emerging technologies, as well as the industry, regulatory, and macroeconomic factors that influence growth prospects.

Medical 105
article thumbnail

The “Medical Bypass”: new drugs to strike obesity

Pharmaceutical Technology

The company’s weight loss drug Saxenda (liraglutide) won an approval for chronic weight management in December 2014, and Wegovy (semaglude) got the same tag in 2021. We highlight the most impactful emerging technologies, as well as the industry, regulatory, and macroeconomic factors that influence growth prospects.

Medical 98